Centessa Pharmaceuticals

Youtube Subscribe

Open: 5.94 Close: 6.14 Change: 0.2

Don't invest before reading what an AI found about Centessa Pharmaceuticals Company Inc.

This document will help you to evaluate Centessa Pharmaceuticals without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Centessa Pharmaceuticals are: Centessa, Pharmaceuticals, plc, year, last, issue, quarterly, …

Concept Map

Semantic Network

Stock Summary

Centessa Pharmaceuticals plc has a 1-year low of $3.00 and a 1 year high of $8.65. Centessa focused on asset-centric, patient-centric drug development. The word on The Street.

Today's Summary

Centessa Pharmaceuticals plc has a 1-year low of $3.00 and a 1 year high of $8.65. Centessa focused on asset-centric, patient-centric drug development. The word on The Street in general, suggests a Moderate Buy analyst consensus.

Today's News

Centessa Pharmaceuticals plc has a 1-year low of $3.00 and a 1 year high of $8.65. The company last issued its quarterly earnings data on Monday, August 14th. Centessa Pharmaceuticals ( NASDAQ:CNTA – Get Free Report ) last issued its quarterly earnings data on Monday, August 14th. Analysts expect that Centessa. Pharmaceuticals plc will post -1.74 EPS for the current year. Centessa focused on asset-centric, patient-centric drug development. BMO Capital analyst Kostas Biliouris maintained a Buy rating on Centessa Pharmaceuticals today and set a price target of $15.00. The word on The Street in general, suggests a Moderate Buy analyst consensus rating.

Stock Profile

" Centessa Pharmaceuticals plc has a 1-year low of $3.00 and a 1 year high of $8.65. The company last issued its quarterly earnings data on Monday, August 14th. Centessa Pharmaceuticals ( NASDAQ:CNTA – Get Free Report ) last issued its quarterly earnings data on Monday, August 14th. Analysts expect that Centessa. Pharmaceuticals plc will post -1.74 EPS for the current year. Centessa focused on asset-centric, patient-centric drug development. BMO Capital analyst Kostas Biliouris maintained a Buy rating on Centessa Pharmaceuticals today and set a price target of $15.00. The word on The Street in general, suggests a Moderate Buy analyst consensus rating."

Keywords

How much time have you spent trying to decide whether investing in Centessa Pharmaceuticals? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Centessa Pharmaceuticals are: Centessa, Pharmaceuticals, plc, year, last, issue, quarterly, and the most common words in the summary are: pharmaceutical, follow, centessa, nasdaq, stock, share, best, . One of the sentences in the summary was: The word on The Street in general, suggests a Moderate Buy analyst consensus.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pharmaceutical #follow #centessa #nasdaq #stock #share #best.

Read more →

Youtube Subscribe

---